Whereas in control mice CD45+ cells had infiltrated lung, liver, bone, and spleen, in treated mice these cells were almost undetectable in the tissues examined (Figure S5B) indicating that PR-104 treatment not only prolonged survival but also resulted in marked reduction of tissue infiltrating leukemia cells. This evidence concerns the gene PTPRC and leukemia.